INS 2026 Virtual Conference

The INS 2026 Virtual Conference is a great option for anyone who can’t join us in person. With 20 curated sessions available virtually and on-demand, CRNI®s can earn up to 40 recertification units (RUs) at their own pace. This year’s virtual lineup includes 3 specialty tracks—Vascular Access Devices, Alternative Care Settings, and Disease States—each designed to strengthen your infusion therapy practice from anywhere.

  • Contains 3 Component(s), Includes Credits Includes a Live Web Event on 04/12/2026 at 8:00 AM (EDT)

    Vascular access device (VAD) selection is a complex and evolving part of infusion therapy practice. The key foundational concept to VAD selection is vessel health and preservation, selecting the optimal VAD that will support administration of required infusion therapy while maintaining patient safety. It includes 4 basic segments: patient specific assessment and appropriate VAD selection, skilled clinician VAD insertion, VAD management to promote positive outcomes, and analyzing organizational data to identify areas for improvement. The choice of the correct VAD for placement is reliant on thorough understanding of VAD and infusate characteristics within the context of the individual patient’s condition and infusion therapy requirements. This session will review the risks and benefits of VAD options, the infusate components that increase injury risk, then apply those criteria to promote patient safety through to a case-based discussion from various clinical settings.

    Vascular access device (VAD) selection is a complex and evolving part of infusion therapy practice. The key foundational concept to VAD selection is vessel health and preservation, selecting the optimal VAD that will support administration of required infusion therapy while maintaining patient safety. It includes 4 basic segments: patient specific assessment and appropriate VAD selection, skilled clinician VAD insertion, VAD management to promote positive outcomes, and analyzing organizational data to identify areas for improvement. The choice of the correct VAD for placement is reliant on thorough understanding of VAD and infusate characteristics within the context of the individual patient’s condition and infusion therapy requirements. This session will review the risks and benefits of VAD options, the infusate components that increase injury risk, then apply those criteria to promote patient safety through to a case-based discussion from various clinical settings.

    Learning Objectives: At the conclusion of this session, learners will be able to:

    •    Describe characteristics of peripheral and central vascular access devices through risk/analysis perspective

    •    Identify infusate components that increase the risk of patient injury

    •    Apply VAD and infusate characteristics in a case scenario format to optimize patient safety

    Contact Hours: 1

    CRNI® RUs: 2

    Barb Nickel, APRN-CNS, CCRN, CRNI®

    Clinical Nurse Specialist

    CommonSpirit Health

    Barb Nickel, APRN-CNS, CCRN, CRNI® is a Clinical Nurse Specialist at a large health care system in the United States, responsible for staff development and process improvement to optimize outcomes in multiple areas of clinical practice, including critical care, infusion therapy, sepsis, and new graduate transition to practice. Ms Nickel has presented nationally and internationally and published in several peer-review journals on infusion-related topics. She was the chair of the 2024 INS Infusion Therapy Standards of Practice Committee, and is now chair of the 2027 Standards Committee. She also serves as Adjunct Research Fellow for Griffith University, Queensland, Australia.

  • Contains 3 Component(s), Includes Credits Includes a Live Web Event on 04/12/2026 at 8:00 AM (EDT)

    Intravascular catheters are among the most frequently used medical devices in healthcare. Their widespread use—across millions of insertions, access procedures, and maintenance events—significantly increases the risk of healthcare-associated infections. The purpose of this presentation is to provide a framework that vascular access team (VAT) members can use to reduce the risk of post-insertion infections associated with vascular access devices (VADs). Recent U.S. and international infection prevention (IP) research highlights a growing number of emerging issues and recommended interventions relevant to vascular access teams (VATs). These include hand hygiene adherence, proper use of personal protective equipment, and environmental exposure risks such as contaminated sinks. New federal legislation on hospital-onset bacteremia has expanded prevention efforts to all VADs, not just central lines. Additional focus areas include defining core components of infection risk mitigation, gaining leadership support, and optimizing catheter placement to reduce infection. Advances in antimicrobial dressings, blood culture contamination reduction, and updated IP strategies for peripheral IVs are also emphasized. Finally, monitoring post-insertion care with attention to bundle compliance remains a key priority. A review of emerging IP issues will inform necessary updates to VAD clinical practice protocols. These revisions aim to enhance patient safety by strengthening infection prevention across assessment, insertion, and maintenance practices.

    Intravascular catheters are among the most frequently used medical devices in healthcare. Their widespread use—across millions of insertions, access procedures, and maintenance events—significantly increases the risk of healthcare-associated infections.  

    The purpose of this presentation is to provide a framework that vascular access team (VAT) members can use to reduce the risk of post-insertion infections associated with vascular access devices (VADs). Recent U.S. and international infection prevention (IP) research highlights a growing number of emerging issues and recommended interventions relevant to vascular access teams (VATs). These include hand hygiene adherence, proper use of personal protective equipment, and environmental exposure risks such as contaminated sinks.  

    New federal legislation on hospital-onset bacteremia has expanded prevention efforts to all VADs, not just central lines. Additional focus areas include defining core components of infection risk mitigation, gaining leadership support, and optimizing catheter placement to reduce infection. Advances in antimicrobial dressings, blood culture contamination reduction, and updated IP strategies for peripheral IVs are also emphasized.  

    Finally, monitoring post-insertion care with attention to bundle compliance remains a key priority. A review of emerging IP issues will inform necessary updates to VAD clinical practice protocols. These revisions aim to enhance patient safety by strengthening infection prevention across assessment, insertion, and maintenance practices. 

    Learning Objectives: By the end of this session, participants will be able to: 

    • Summarize the emerging IP issues that will influence VAD practice. 
    • Summarize new peer-reviewed studies and expert guideline recommendations that impact VAD practice. 
    • Reproduce a listing of emerging IP intervention considerations that reflect recent research findings. 

    Contact Hours: 1

    CRNI® RUs: 2

    Robert Garcia, MT(ASCP), CIC, FAPIC

    Infection Prevention Consultant

    Enhanced Epidemiology LLC

    Robert Garcia is an infection preventionist/consultant and has been a member of the Association for Professionals in Infection Control and Epidemiology (APIC) since 1980. In 2016, he was selected as a fellow at the Association for Professionals in Infection Control and Epidemiology (APIC), a designation for experienced IPs who have had significant contributions to the field of infection prevention. He is the certification infection preventionist/director at nine hospitals in New York City and the principal researcher on the effectiveness of silver-hydrogel urinary catheters, chlorhexidine skin antisepsis, and comprehensive oral care. Robert is a current or former member of APIC’s National Strategic Planning Board, Education Committee, and/or CBIC, as well as a trainer for APIC’s EPI Clinical Course. He is a contributor to APIC’s Text of Infection Control and Epidemiology; was a reviewer for the 2005 HICPAC Guidelines on Isolation; and since 2001 has been an editorial board member and/or reviewer for the American Journal of Infection Control, where in 2016 he was ranked among the top 25th percentile of reviewers. He has more than 100 publications and media interviews ranging from institutional costs of infection to prevention of HAIs to environmental contamination to microbiology to reducing occupational exposures.

  • Contains 3 Component(s), Includes Credits Includes a Live Web Event on 04/12/2026 at 9:15 AM (EDT)

    Catheter-associated bloodstream infection (CABSI) prevention has traditionally focused on 2 primary routes: skin flora migration along the catheter (extraluminal) and contamination introduced through the hub (intraluminal). Yet a third pathway—gross “outside-in” contamination from environmental or body fluids—remains underrecognized and largely absent from current infection-prevention (IP) bundles. The “What is Missing” concept addresses this overlooked pathway, taking a closer look at targeted interventions. This session examines the evidence for this neglected route, its clinical consequences, and the procedural vulnerabilities that permit it. This presentation highlights the urgent need to address this gap in protection and will review practical solutions for clinicians in all settings. Integrating these strategies into vascular access practices supports a systems-based approach to improve infection control to close the gap between ideal protocols and real-world practice.

    Catheter-associated bloodstream infection (CABSI) prevention has traditionally focused on 2 primary routes: skin flora migration along the catheter (extraluminal) and contamination introduced through the hub (intraluminal). Yet a third pathway—gross “outside-in” contamination from environmental or body fluids—remains underrecognized and largely absent from current infection-prevention (IP) bundles. The “What is Missing” concept addresses this overlooked pathway, taking a closer look at targeted interventions. This session examines the evidence for this neglected route, its clinical consequences, and the procedural vulnerabilities that permit it. This presentation highlights the urgent need to address this gap in protection and will review practical solutions for clinicians in all settings. Integrating these strategies into vascular access practices supports a systems-based approach to improve infection control to close the gap between ideal protocols and real-world practice. 

    Learning Objectives: At the conclusion of this session, learners will be able to:  

    • Identify the 3 primary routes of CABSI, including the underrecognized “outside-in” contamination pathway 
    • Analyze real-world evidence and case data to determine the role of gross environmental contamination in the development of CABSI 
    • Evaluate the limitations of current infection prevention practices and technologies in addressing visible contamination of vascular access components 
    • Recommend practical, system-based interventions to reduce the risk of catheter-related infections in clinical practice 

    Contact Hours: 1

    CRNI® RUs: 2

    Nancy Moureau, PhD, RN, CRNI®, CPUI™, VA-BC

    CEO

    PICC Excellence

    Nancy Moureau, PhD, RN, CRNI®, CPUI™, VA-BC, is a globally recognized leader and the founder of PICC Excellence, Inc, a premier provider of education on infusion therapy and vascular access device (VAD) insertion and care for over 30 years. Dr Moureau’s extensive clinical experience includes pediatric, neonatal, intensive care unit (ICU) peripherally inserted central catheter (PICC)/IV teams, and home infusion care.

    As CEO of PICC Excellence, she leads the development of over 100 online educational courses and pathways, emphasizing insertion competency and evidence-based practices. Her responsibilities include education development, research, global speaking engagements, legal reviews, manufacturer consulting, and active clinical practice for peripheral and central vascular access.

    Dr Moureau pioneered PICC Certification™ (CPUI™) and Neonatal PICC Credentialing (CNPI) programs, validating inserters' education and competency. Most recently, she introduced a systematic UGPIV Mastery Learning Process, an ultrasound-guided peripheral insertion toolbox that earned the INS’s Seal of Approval—the first of its kind.

  • Contains 3 Component(s), Includes Credits Includes a Live Web Event on 04/12/2026 at 9:15 AM (EDT)

    Peripheral intravenous catheter (PIVC) vasopressor administration is increasingly used to expedite the treatment of sepsis when central venous access is not immediately available. National guidelines now support short-term peripheral administration of vasopressors in adults. This session will review a multi-hospital health care system study of PIVC vasopressor use focusing on both a retrospective chart review as well as qualitative exploration of nurses’ perspectives on guideline implementation. Findings highlight the importance of adhering to standardized guidelines to minimize complications from peripheral vasopressor use and emphasize nurses’ key role in safe implementation. Evidence supports the safe use of peripheral vasopressors when guided by evidence-based guidelines and underscores the need for prospective, multicenter research to refine best practices and inform national standards.

    Peripheral intravenous catheter (PIVC) vasopressor administration is increasingly used to expedite the treatment of sepsis when central venous access is not immediately available. National guidelines now support short-term peripheral administration of vasopressors in adults. This session will review a multi-hospital health care system study of PIVC vasopressor use focusing on both a retrospective chart review as well as qualitative exploration of nurses’ perspectives on guideline implementation. Findings highlight the importance of adhering to standardized guidelines to minimize complications from peripheral vasopressor use and emphasize nurses’ key role in safe implementation. Evidence supports the safe use of peripheral vasopressors when guided by evidence-based guidelines and underscores the need for prospective, multicenter research to refine best practices and inform national standards. 

    Learning ObjectivesAt the conclusion of this session, learners will be able to:  

    1. Describe the key components of national guidelines for peripheral vasopressor administration in adult sepsis patients 
    2. Explain the relationship between adherence to peripheral vasopressor guidelines and the occurrence of complications 
    3. Discuss frontline nurses’ perspectives and confidence levels in administering vasopressors through PIVCs and identify strategies to improve practice adherence 

    Contact Hours: 1
    CRNI® RUs: 2

    Joan Harvey, DNP, MSN, RN, GERO-BC, CCRN

    Nurse Scientist

    Hackensack Meridian Health

    Joan Harvey, DNP, MSN, RN, GERO-BC, CCRN, is a Program Manager and Nurse Scientist at Hackensack Meridian Health and Director of the Accelerated BSN Program at Georgian Court University. She has more than 40 years of nursing experience, with progressive leadership roles in critical care, nursing education, gerontology, and clinical research. Dr Harvey has served as principal or co-investigator on multiple studies focused on geriatric care, nurse well-being, staffing, fatigue, and evidence-based practice, and she is the author of peer-reviewed publications in the Journal of Nursing Leadership, Nursing Administration Quarterly, and Journal of Nursing Management. Her professional achievements include the New Jersey Governor’s Award for Nursing Excellence and the Nightingale Award. Dr Harvey is a frequent national and regional speaker on nursing research, workforce resilience, and quality improvement.

    Susan H. Weaver, PhD, RN, CRNI®, NEA-BC

    Nurse Scientist, Hackensack Meridian Health

    Susan Heidenwolf Weaver, PhD, RN, CRNI®, NEA-BC, is a nurse scientist at the Ann May Center for Nursing at Hackensack Meridian Health and the New Jersey Collaborating Center for Nursing. Sue has experience as an ICU nurse and Nurse Educator, with responsibility for teaching the IV Course, Operations Manager and Evening Administrative Supervisor. As a nurse scientist, Sue has conducted research on the nursing workforce, with a focus on the evening and night administrative supervisor role. Sue has presented and has been published on critical “behind the scenes” nurse leadership roles. Sue lives in Lake Mohawk, New Jersey, has 3 great children and is a basket weaver!

  • Contains 3 Component(s), Includes Credits Includes a Live Web Event on 04/12/2026 at 10:30 AM (EDT)

    More information coming soon...

    More information coming soon...

    Contact Hours: 1

    CRNI® RUs: 2

    Karen Meade, MS, APRN-CNS, AGCNS-BC, OCN

    Clinical Nurse Specialist

    The James Cancer Hospital at The Ohio State Wexner Medical Center

    Karen Meade, MS, APRN-CNS, AGCNS-BC, OCN, is an oncology Clinical Nurse Specialist at The James Cancer Hospital at The Ohio State University Wexner Medical Center, with more than 8 years of experience in the Clinical Nurse Specialist role and prior experience as a Senior Infusion Quality Manager. Her work has focused on advancing infusion safety and quality, including leading the go-live of IV smart pump interoperability and supporting evidence-based infusion practices across diverse patient populations. Ms Meade is currently pursuing her PhD in Nursing at the University of Massachusetts Amherst, with research interests centered on medication safety, infusion practices, and the use of data to inform oncology nursing care.

  • Contains 3 Component(s), Includes Credits Includes a Live Web Event on 04/12/2026 at 10:30 AM (EDT)

    Sepsis is a life-threatening response to infection and a leading cause of death and costly hospitalizations in the United States, disproportionately affecting older adults. This presentation will explore differences between community- and hospital-acquired sepsis, its pathophysiology, and the physical and cognitive challenges survivors often face. Through case examples and educational resources from a sepsis nurse expert, attendees will gain tools to raise awareness, recognize early signs, and improve patient outcomes across the continuum of care.

    Sepsis is a life-threatening response to infection and a leading cause of death and costly hospitalizations in the United States, disproportionately affecting older adults. This presentation will explore differences between community- and hospital-acquired sepsis, its pathophysiology, and the physical and cognitive challenges survivors often face. Through case examples and educational resources from a sepsis nurse expert, attendees will gain tools to raise awareness, recognize early signs, and improve patient outcomes across the continuum of care. 

    Learning Objectives: At the conclusion of this session, learners will be able to:  

    • Describe the incidence, mortality, and cost burden of sepsis, differentiating between community-acquired and hospital-acquired cases 
    • Explain the pathophysiology of sepsis, including its progression from sepsis to severe sepsis and septic shock, and identify early signs and symptoms 
    • Discuss the impact of sepsis on vulnerable populations, especially older adults, including long-term functional, cognitive, and psychological effects 
    • Analyze the role of central line-associated bloodstream infections (CLABSIs) in sepsis and evaluate prevention strategies to reduce infection risk 
    • Apply sepsis screening tools and care bundles in clinical practice while identifying resources and strategies to empower patients, caregivers, and health care professionals in sepsis awareness, prevention, and management  

    Contact Hours: 1
    CRNI® RUs: 2

    Claudia Orth, BSN, RN

    Director, Professional Education & Training

    Sepsis Alliance

    Claudia Orth, BSN, RN, earned her BSN from Northeastern University in Boston, Massachusetts, and has over 20 years of experience working as a registered nurse in critical care, clinical quality, patient safety, and sepsis.

    In her role as the Director of Professional Education and Training, she oversees all health care professional education programming and activities, including the newly relaunched Sepsis Alliance Institute, which encompasses the online, free to join, Sepsis Alliance Institute Learning Management System (LMS) and the Sepsis Alliance Institute clinical community, where health care professionals can learn, share resources, and engage in peer-to-peer networking and clinical discussions.

    Prior to joining Sepsis Alliance, Ms Orth spent 9 years serving as the inaugural Sepsis Coordinator for northern Michigan’s largest health system. In that role she collaborated with multi-disciplinary stakeholders to implement a robust sepsis program and developed evidence-based electronic early warning alerts, screening tools, and order sets. She also led system-wide didactic, and high- and low-fidelity simulation education, and performed data abstraction and data analysis to identify key performance improvement opportunities for the organization.

    In her free time, she loves watching her 2 children play sports, spending time with family and friends, traveling, cooking, and taking advantage of all the beautiful bodies of water and surrounding nature that northern Michigan has to offer.

  • Contains 3 Component(s), Includes Credits Includes a Live Web Event on 04/12/2026 at 2:30 PM (EDT)

    Intravenous smart pumps (IVSPs) have become indispensable tools in modern infusion therapy, supporting nurses in accurate and safe medication delivery. Despite their ubiquity in United States hospitals, IVSP data, which may include alarms, alerts, keystrokes, and infusion status, remain an underutilized resource for nursing-led quality improvement. This presentation explores how IVSP data can illuminate gaps in clinical practice and support nursing-driven interventions to improve safety and efficiency. This session will demonstrate how nursing perspectives are essential in interpreting IVSP data, advocate for nurse access to data platforms, and highlight opportunities for real-time problem solving that bridges technology and patient care.

    Intravenous smart pumps (IVSPs) have become indispensable tools in modern infusion therapy, supporting nurses in accurate and safe medication delivery. Despite their ubiquity in United States hospitals, IVSP data, which may include alarms, alerts, keystrokes, and infusion status, remain an underutilized resource for nursing-led quality improvement. This presentation explores how IVSP data can illuminate gaps in clinical practice and support nursing-driven interventions to improve safety and efficiency. This session will demonstrate how nursing perspectives are essential in interpreting IVSP data, advocate for nurse access to data platforms, and highlight opportunities for real-time problem solving that bridges technology and patient care. 

    Learning ObjectivesAt the conclusion of this session, learners will be able to:  

    1. Explain how infusion pump data is collected and interpreted, including distinctions between alerts and alarms 
    2. Describe a real-world example of how nursing interpretation of IVSP data informed clinical practice changes or system-level enhancements at a large academic medical center 
    3. Identify at least 2 types of infusion pump data nurses can use to improve practice 
    4. Discuss strategies to increase nursing engagement with infusion pump analytics and vendor partnerships 

    Contact Hours: 1
    CRNI® RUs: 2

    Jeannine Blake, PhD, RN

    Assistant Professor

    University of Massachusetts Amherst

    Jeannine WC Blake, PhD, RN, is an Assistant Professor at the Elaine Marieb College of Nursing as an Assistant Professor affiliated with the Elaine Marieb Center for Nursing and Engineering Innovation at the University of Massachusetts Amherst. Dr Blake has a clinical background in surgical intensive care nursing, PhD in Nursing Science, and PostDoctoral Research Fellowship in Mechanical and Industrial Engineering. Her research is focused on IV smart pump flow rate accuracy, variability, usability and alarming behavior. She acts as an advisor to hospitals, device companies, and infusion standards committees.

    Karen Meade, MS, APRN-CNS, AGCNS-BC, OCN

    Clinical Nurse Specialist

    The James Cancer Hospital at The Ohio State Wexner Medical Center

    Karen Meade, MS, APRN-CNS, AGCNS-BC, OCN, is an oncology Clinical Nurse Specialist at The James Cancer Hospital at The Ohio State University Wexner Medical Center, with more than 8 years of experience in the Clinical Nurse Specialist role and prior experience as a Senior Infusion Quality Manager. Her work has focused on advancing infusion safety and quality, including leading the go-live of IV smart pump interoperability and supporting evidence-based infusion practices across diverse patient populations. Ms Meade is currently pursuing her PhD in Nursing at the University of Massachusetts Amherst, with research interests centered on medication safety, infusion practices, and the use of data to inform oncology nursing care.

  • Contains 3 Component(s), Includes Credits Includes a Live Web Event on 04/12/2026 at 2:30 PM (EDT)

    Patients with hypercoagulable conditions present unique challenges for vascular access clinicians. Choosing the most appropriate vascular access device (VAD) requires balancing infusion therapy needs, vessel health preservation, and minimizing thrombosis risk. This session will explore hypercoagulable disease states, such as cancer-associated thrombosis, antiphospholipid antibody syndrome, and inherited thrombophilias, and discuss how each impacts device selection, dwell time, and maintenance practices. Attendees will review current evidence, clinical guidelines, and case scenarios that highlight the intersection of pathophysiology, device choice, and patient outcomes.

    Patients with hypercoagulable conditions present unique challenges for vascular access clinicians. Choosing the most appropriate vascular access device (VAD) requires balancing infusion therapy needs, vessel health preservation, and minimizing thrombosis risk. This session will explore hypercoagulable disease states, such as cancer-associated thrombosis, antiphospholipid antibody syndrome, and inherited thrombophilias, and discuss how each impacts device selection, dwell time, and maintenance practices. Attendees will review current evidence, clinical guidelines, and case scenarios that highlight the intersection of pathophysiology, device choice, and patient outcomes.

    Learning ObjectivesAt the conclusion of this session, learners will be able to:  

    • Identify common hypercoagulable disease states encountered in infusion and vascular access practice 
    • Analyze how hypercoagulability influences the risk profile for peripherally inserted central catheters (PICCs)midline catheters, ports, and tunneled catheters 
    • Apply evidence-based strategies to guide VAD selection and management for patients with elevated thrombotic risk 
    • Integrate risk-mitigation approaches into patient education, insertion practices, and ongoing device maintenance 

    Contact Hours: 1
    CRNI® RUs: 2

    Britt Meyer, PhD, RN, CRNI®, VA-BC, NE-BC

    Nurse Manager Operations Vascular Access Team

    Duke Hospital

    Britt Meyer, PhD, RN, CRNI®, VA-BC, NE-BC, chair of the Infusion Nurses Certification Corporation (INCC), leads the vascular access team at Duke University Hospital and presents nationally and internationally on a variety of infusion and vascular access topics. She is well-published in the specialty and is passionate about empowering clinicians to provide safe and effective care. She also serves as an adjunct faculty member for the East Carolina University School of Nursing and is a member of the INS Standards Committee for the 10th edition.

  • Contains 3 Component(s), Includes Credits Includes a Live Web Event on 04/13/2026 at 8:00 AM (EDT)

    Home parenteral nutrition (HPN) requires long-term vascular access through central venous catheters or implanted ports. Recent meta-analytic evidence in young patients demonstrated significant psychological effects, including elevated anxiety, depression, and body image disturbances. However, lived experiences and coping strategies of adult HPN patients remain inadequately understood, limiting targeted psychosocial support development. This session will illustrate findings to inform targeted psychosocial screening tools and intervention protocols, contributing to evidence-based guidelines for interdisciplinary HPN care teams emphasizing psychological well-being alongside clinical management.

    Home parenteral nutrition (HPN) requires long-term vascular access through central venous catheters or implanted ports. Recent meta-analytic evidence in young patients demonstrated significant psychological effects, including elevated anxiety, depression, and body image disturbances. However, lived experiences and coping strategies of adult HPN patients remain inadequately understood, limiting targeted psychosocial support development. This session will illustrate findings to inform targeted psychosocial screening tools and intervention protocols, contributing to evidence-based guidelines for interdisciplinary HPN care teams emphasizing psychological well-being alongside clinical management. 

    Learning ObjectivesAt the conclusion of this session, learners will be able to:  

    1. Identify the key psychological impacts of long-term vascular access devices in home parenteral nutrition patients, including anxiety, depression, body image disturbances, and social functioning concerns based on current meta-analytic evidence 
    2. Assess patients for signs of psychological distress related to vascular access devices using evidence-based screening approaches and recognize when referral to mental health professionals is warranted 
    3. Implement patient-centered communication strategies that address psychological concerns about vascular access devices, including techniques for discussing body image, lifestyle modifications, and coping strategies with HPN patients 
    4. Develop individualized psychosocial support plans for HPN patients with vascular access devices, incorporating peer support resources, family education, and interdisciplinary collaboration to optimize psychological well-being and treatment adherence 

    Contact Hours: 1
    CRNI® RUs: 2

    Baudolino Mussa, MD, PhD

    Cvc Team Director

    Università di Torino

    Baudolino Mussa, MD, PhD, is a Professor of Surgery and the Vascular Access Team Director at the University of Turin. He is the founder and past-President of the Italian Vascular Access Society (IVAS). For over 25 years, he has been a lead author on numerous international publications and an invited speaker at many national and international conferences on the development and responsibilities of vascular access teams in Europe, most recently at INS 2025 . 

    His career combines clinical excellence, research innovation, and educational leadership.

    Dr Mussa’s most significant research contributions are in vascular access research, with landmark studies including analysis of 169,000+ catheter-days in cancer patients; safety studies of 100,000+ peripherally-inserted central catheters; and development of European vascular access guidelines. He has published 8 peer-reviewed articles in major journals, with a focus on large-scale clinical studies with an emphasis on patient safety and clinical outcomes.

    As for clinical leadership, Dr Mussa performs 150+ surgical procedures annually; places approximately 800 vascular access devices yearly; and coordinates a team, managing 7,000+ patients annually.

    Dr Mussa is President of the Italian Vascular Access Society, a member of the Multidisciplinary Advanced Course on Vascular Access (MACOVA) board, and a lead instructor for international training programs in Asia.

    Dr Mussa’s work has significantly influenced clinical practice through evidence-based protocols, educational innovation, and quality improvement initiatives, establishing him as a key figure in vascular access medicine.

  • Contains 3 Component(s), Includes Credits Includes a Live Web Event on 04/13/2026 at 8:00 AM (EDT)

    Peripheral intravenous infiltrations and extravasations (PIVIEs) remain a significant source of preventable harm, patient distress, and healthcare cost, especially in pediatric settings, where families often cite intravenous (IV) starts and failures as the most stressful part of a hospitalization. With over 80% of hospitalized patients requiring a peripheral intravenous catheter (PIVC), proactive prevention strategies are essential. This session introduces and discusses the P.O.K.E. initiative (Previous PIVIE, Oral transition, Keep it, Educate PIV plan to family and team), a structured communication tool designed to reduce PIVIE rates through interdisciplinary collaboration and family engagement.

    Peripheral intravenous infiltrations and extravasations (PIVIEs) remain a significant source of preventable harm, patient distress, and healthcare cost, especially in pediatric settings, where families often cite intravenous (IV) starts and failures as the most stressful part of a hospitalization. With over 80% of hospitalized patients requiring a peripheral intravenous catheter (PIVC), proactive prevention strategies are essential. This session introduces and discusses the P.O.K.E. initiative (Previous PIVIE, Oral transition, Keep it, Educate PIV plan to family and team), a structured communication tool designed to reduce PIVIE rates through interdisciplinary collaboration and family engagement.  

    Learning Objectives: At the conclusion of this session, learners will be able to:  

    • Understand the complications associated with PIVIE and their impact on the child, the family, and the health care system 
    • Identify evidence-based tools for the prevention of PIVIE 
    • Evaluate current PIVIE prevention strategies implemented to determine alignment with evidence-based best practices and identify opportunities for improvement 
    • Recognize key risk factors that contribute to its occurrence in pediatric patients 

    Contact Hours: 1

    CRNI® RUs: 2

    Julie Marshall, DNP, RN, CCM, CNE, PED-BC

    Clinical Practice Specialist

    Children's Hospital Colorado

    Julie Ann Marshall, DNP, RN, CCM, CNE, PED-BC, has been a pediatric nurse for over 20 years and is certified in pediatric nursing, case management, and as a certified nurse educator. She is celebrating her 20th year at Children’s Colorado and serves as the Clinical Practice Specialist for MedSurg in Colorado Springs. Her passion is to bridge evidence-based practice and quality improvement work to clinical nurses at the bedside to empower all nurses as change agents to drive improved outcomes. Dr Marshall’s current focuses are pediatric fall prevention, nurse-led rounds, and pediatric needle pain mitigation.

    She has many years of clinical nursing experience, teaching practice to nursing students, new graduate nurses in a residency program, online distance learning, hospital-based and academic-based education. Dr Marshall is a member of the Association of Pediatric Hematology/Oncology Nurses and the Society of Pediatric Nurses. She has completed many quality improvement and evidence-based practice projects and has disseminated at national conferences and locally in Colorado. 

    Dr Marshall’s passion is to bridge evidence-based practice and quality improvement work to clinical nurses at the bedside to empower all nurses as change agents to drive improved outcomes. She strongly believes that all nurses are leaders, with or without a title. Her mission is to continue to mentor, develop, teach, and model the profession of pediatric nursing for future and current nurses, completing this through a dedication to lifelong learning and championing a safe and just culture. Dr Marshall has also served on global medical mission trips and local medical missions, and volunteers at a local hospice agency to provide companionship for the dying. 

    Jessica L. Perdue, DNP, MS, RN, NPD-BC, CPN

    Clinical Practice Specialist

    Children's Hospital Colorado

    Jessica L. Perdue, DNP, MS, RN, NPD-BC, CPN, is a Clinical Practice Specialist at Children’s Hospital Colorado with more than 25 years of pediatric nursing experience and focused expertise in infusion therapy-related quality improvement and patient safety. 

    Dr Perdue has led organization-wide initiatives to reduce peripheral intravenous infiltration and extravasation (PIVIE) through standardized assessment, workflow redesign, policy revision, and competency-based education across emergency, urgent care, and inpatient settings. Her work emphasizes data-driven quality improvement, interdisciplinary collaboration, and alignment with INS standards.